Results 101 to 110 of about 44,633 (211)

Speckle Tracking and Transthyretin Amyloid Cardiomyopathy

Arquivos Brasileiros de Cardiologia
Background: Amyloidosis is a disease caused by deposits of insoluble fibrils in extracellular spaces. The most common type of familial amyloidosis is mediated by mutation of transthyretin, especially Val30Met.
Alexandre Marins Rocha, Suzane Garcia Ferreira, Marcelo Souto Nacif, Mario Luiz Ribeiro, Marcos Raimundo Gomes de Freitas, Cláudio Tinoco Mesquita   +5 more
doaj   +1 more source

Palinacousis in amyloidosis: exploring the hallucinatory phenomenon in brain pathology—a case report

Journal of Medical Case Reports
Background Hereditary transthyretin amyloidosis, caused by transthyretin gene mutations, progresses with systemic impact and often presents peripheral neuropathy.
João Martins-Correia, Luísa Sousa
doaj   +1 more source

A mutation in transthyretin gene in a Mexican patient leading to hereditary amyloidosis: a case report

Journal of Medical Case Reports
Background Transthyretin is a protein produced by the liver, and when normal, it carries out the role of transporting thyroid hormone and vitamin A in the body. Mutations in the gene that codes for this protein can cause it to misfold.
Muhammad Reebal Malik, Tarun Dalia, Zubair Shah   +2 more
doaj   +1 more source

Treatment of Acquired Transthyretin Amyloidosis in Domino Liver Transplantation

, 2023
BACKGROUND: Domino liver transplantation (DLT) has been commonly used during the last two decades to partly meet the high need for liver transplants.
Giannopoulos, Sotirios, Sarmas, Ioannis, Mytilinaios, Dimitrios, Tsamis, Konstantinos I, Gilbertson, Janet A, Gillmore, Julian D, Heneghan, Michael, Konitsiotis, Spyridon   +7 more
core   +1 more source

What's new in the treatment of amyloidosis? Part 2: Cardiomyopathy due to transthyretin amyloidosis

Revista del Hospital Italiano de Buenos Aires
Transthyretin deposition amyloidosis is a rare disease caused by the deposition of fibrils of this protein in various tissues, although the most common manifestations are cardiac and neurological.
Gisela Bendelman, Marcelina Carretero, Diego Pérez de Arenaza, Eugenia Villanueva, Erika B. Brulc, Elsa M. Nucifora, María A. Marco, María S. Sáez, Patricia Sorroche, María A. Aguirre, María L. Posadas Martínez   +10 more
doaj   +1 more source

Polyneuropathy in hereditary and wildtype transthyretin amyloidosis, comparison of key clinical features and red flags

Scientific Reports
Transthyretin (TTR) amyloidosis manifests in two distinct forms: hereditary (ATTRv) and wild-type transthyretin amyloidosis (ATTRwt). Despite being one of the commonest manifestations in ATTRv amyloidosis, the presence of polyneuropathy has long been ...
Janna M. Siemer, Lea Grote-Levi, Anja Hänselmann, Mieke L. Sassmann, Sandra Nay, Dominica Ratuszny, Sonja Körner, Tabea Seeliger, Martin W. Hümmert, Maike F. Dohrn, André Huss, Hayrettin Tumani, Vega Gödecke, Michael Heuser, Johann Bauersachs, Udo Bavendiek, Thomas Skripuletz, Stefan Gingele   +17 more
doaj   +1 more source

Advances in the treatment of transthyretin amyloidosis

eGastroenterology
This review aims to provide a comprehensive overview of the existing therapeutic options for managing neuropathic and/or cardiac manifestations associated with transthyretin amyloidosis (ATTR), along with investigational therapeutic candidates under evaluation in ongoing clinical trials.
openaire   +4 more sources

Combination surgery for pressure control in glaucoma from transthyretin amyloidosis, 3-year follow-up

Indian Journal of Ophthalmology. Case Reports
Transthyretin amyloidosis is a known cause of secondary glaucoma. The authors present a 3-year update on a previously published patient who underwent Kahook Dual Blade (KDB) excisional goniotomy in the right eye, followed by KDB combined with cataract ...
Natalie Brossard-Barbosa, Valentina Campisi, Naomi E Gutkind, Carla Salina Indovino, Uriel Rubin, Tomas M Grippo   +5 more
doaj   +1 more source

Tafamidis Reduces Death and Hospitalization for Acute Heart Failure in Octogenarian Patients With Transthyretin Cardiac Amyloidosis: A Propensity Score–Weighted Cohort Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Transthyretin cardiac amyloidosis results from the deposition of misfolded amyloid fibrils in cardiac tissue, leading to progressive heart failure.
Louise Zmuda, Amira Zaroui, Mounira Kharoubi, Emmanuelle Boutin, Frédéric Roca, Silvia Oghina, Emmanuel Teiger, Marie Laurent, Florence Canoui‐Poitrine, Thibaud Damy, Amaury Broussier   +10 more
doaj   +1 more source

TRANSTHYRETIN AMYLOIDOSIS – OVERVIEW OF TREATMENT METHODS

International Journal of Innovative Technologies in Social Science
ATTR amyloidosis is a rare disease associated with abnormal folding of the transthyretin (TTR) protein, leading to the deposition of amyloid fibrils in the heart and nervous system. Treatment to date has focused primarily on alleviating symptoms such as heart failure and neuropathy.
, Hanna Pietruszewska, , Michał Ziemba, , Klaudia Zackiewicz, , Agata Wińska, , Oliwia Sędziak, , Agata Ogórek, , Michał Bzoma, , Paweł Liszka, , Katarzyna Kleszczewska, , Izabela Majchrzak   +9 more
openaire   +1 more source